Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells. (Q53710173)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells.
scientific article

    Statements

    Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit